In vitro antifungal susceptibility of Candida speciesisolated from diabetic patients
Rev. Soc. Bras. Med. Trop
;
51(4): 542-545, July-Aug. 2018. tab
Artigo
em Inglês
| LILACS
| ID: biblio-1041473
ABSTRACT
Abstract INTRODUCTION This study aims to evaluate the antifungal susceptibility of different species of Candida isolated from diabetic patients against eight antifungal agents. METHODS Susceptibility testing of 111 clinical isolates of Candida species was performed against 8 antifungals using the M27-A3 protocol of the Clinical and Laboratory Standards Institute (CLSI). RESULTS Voriconazole, lanoconazole, and caspofungin showed the highest in vitro activity against all the isolates of C. albicans. Resistance against the tested antifungals was only observed in the C. albicans isolates. CONCLUSIONS Our finding revealed that resistance against amphotericin B, itraconazole, ketoconazole, posaconazole, and fluconazole can be observed in C. albicans.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Candida
/
Diabetes Mellitus
/
Antifúngicos
Tipo de estudo:
Guia de Prática Clínica
Limite:
Adulto
/
Idoso
/
Aged80
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
Medicina Tropical
Ano de publicação:
2018
Tipo de documento:
Artigo
País de afiliação:
Irã
Instituição/País de afiliação:
Babol University of Medical Sciences/IR
/
Islamic Azad University/IR
/
Mazandaran University of Medical Sciences/IR
/
Shahid Beheshti University of Medical Sciences/IR
/
Social Security Administration of Amole/IR
Similares
MEDLINE
...
LILACS
LIS